Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

BACKGROUND: The effect of enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade, which represents a patient profile similar to real-world clinical practice in Japan, remains unknown. Therefore, we investigate the efficacy and safety of enz...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Mikio, Kato, Takuma, Tohi, Yoichiro, Shimizu, Yosuke, Matsumoto, Ryuji, Inoue, Takahiro, Takezawa, Yutaka, Masui, Kimihiko, Sasaki, Hiroshi, Hirama, Hiromi, Saito, Shiro, Egawa, Shin, Kamoto, Toshiyuki, Teramukai, Satoshi, Kojima, Shinsuke, Kikuchi, Takashi, Kakehi, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476281/
https://www.ncbi.nlm.nih.gov/pubmed/36104667
http://dx.doi.org/10.1186/s12894-022-01096-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476281/
https://www.ncbi.nlm.nih.gov/pubmed/36104667
http://dx.doi.org/10.1186/s12894-022-01096-3

Ejemplares similares